Brief: Starpharma Posts FY Loss Attributable A$16.2 Million
Aug 25 (Reuters) - Starpharma Holdings SPL.AX :
* FY LOSS ATTRIBUTABLE A$16.2 MILLION
* FY REVENUE FROM CONTINUING OPERATIONS UP 128% TO A$4.9
MILLION
Source text for Eikon: ID:nASX1Q85hM
Further company coverage: SPL.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Starpharma Holdings
See all newsBrief: Starpharma Increases Stake In Petalion To 66% Securing Majority Ownership
Brief: Starpharma Seeks Trading Halt
Brief: Starpharma Holdings Appoints Russell Basser As Chair
Brief: Starpharma Says Fully Underwritten Entitlement Offer To Raise A$32 MLN
Australia's Starpharma slumps to 1-1/2-month low on discounted fund raising